Efficacy and Safety of DKB-119 in Patients in Crow's Feet
Sponsored by Dongkook Pharmaceutical Co., Ltd.
About this trial
Last updated 2 years ago
Study ID
DKB-119-MD-2
Status
Active, not recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
19 to 70 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 2 years ago
What is this trial about?
To prove the non-inferiority of DKB-119 by evaluating the injecting efficacy and safety
DKB-119 and control for patients in crow's feet
What are the participation requirements?
Inclusion Criteria
- Those who are over 19 under 70 ages.
- Those who score 2 or more in the LCL severity evaluation.
- Those who have visually symmetrical crow's feet on both sides.
- Etc.
Exclusion Criteria
- Pregnancy and lactating women.
- Etc.